BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  LabCorp Announces 2019 Third Quarter Results and Updates 2019 Guidance

  LabCorp® announced results for the third quarter ended September 30, 2019, and updated 2019 guidance.

  October 24, 2019

   · 

  23 min read
• Deals

  Predictive Technologies Group PRED Upgrades to OTCQX® Best Market

  Predictive Technology Group, Inc., a leader in the development of genetic and molecular diagnostics and companion therapeutics, announced that the company has been upgraded to the OTCQX® Best Market from the Pink® market.

  October 24, 2019

   · 

  2 min read
• Deals

  Athenex Provides An Update to Shareholders

  Athenex, Inc., a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, provides an update to its shareholders.

  October 24, 2019

   · 

  4 min read
• Drug Development

  Actinium to Announce Interim Results from Pivotal Phase 3 SIERRA Trial on Conference Call Scheduled for Monday, October 28th

  Management will be accompanied by Sergio Giralt, M.D., Chief Attending Physician, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center to present data from 50 percent enrollment in the Phase 3 trial

  October 24, 2019

   · 

  5 min read
• Policy

  U.S. FDA Clears GI Scientific’s ScopeSeal®, the Only Single-Use Disposable Device Indicated to Significantly Reduce Duodenoscope Contamination During ERCP Procedures

  Preserves the superior optical, navigation, air/water and instrument delivery capability of reusable duodenoscopes

  October 24, 2019

   · 

  5 min read
• Business

  Baxter Reports Preliminary Third Quarter 2019 Operating Results

  The Company announces internal investigation of misstatements in previously reported non-operating income related to foreign exchange gains and losses

  October 24, 2019

   · 

  17 min read
• Pharm Country

  Fourth Annual AFTD Benefit Raises More Than $2 Million in Support of Frontotemporal Degeneration Research, Support and Awareness

  The Association for Frontotemporal Degeneration (AFTD) held its annual Hope Rising Benefit on Wednesday night, raising more than $2 million in support of the organization’s mission.

  October 24, 2019

   · 

  3 min read
• Business

  Amgen Announces Webcast of 2019 Third Quarter Financial Results

  Amgen (NASDAQ:AMGN) today announced that it will report its third quarter financial results on Tuesday, Oct. 29, 2019, after the close of the U.S. financial markets.

  October 24, 2019

   · 

  1 min read
• Biotech Bay

  Gilead Sciences Announces Fourth Quarter 2019 Dividend

  Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared a cash dividend of $0.63 per share of common stock for the fourth quarter of 2019.

  October 24, 2019

   · 

  1 min read
• Business

  Cerner Reports Third Quarter 2019 ResultsAll Key Metrics Within Company Guidance Ranges

  Cerner Corporation (Nasdaq: CERN) today announced results for the 2019 third quarter that ended Sept. 28, 2019.

  October 24, 2019

   · 

  23 min read